Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
branding
Biotech
I-Mab unveils new name, strategy, asset and Hong Kong IPO plans
Less than two years after laying out plans to divest its China operations, I-Mab Biopharma is re-staking its claim in the Asia-Pacific region.
Andrea Park
Oct 17, 2025 10:45am
MEI Pharma sheds biotech woes to rebrand as crypto company
Sep 10, 2025 9:58am
NAYA spins off cancer drug business 6 months after INVO merger
Apr 15, 2025 8:05am
Canadian CRO Innovaderm rebrands to Indero
Mar 11, 2025 5:45am
Biotech naming trends bypass 'buzzwords and business speak'
Apr 16, 2024 8:30am
#FierceMadness: The Best Biotech Name Tournament—CHAMPIONSHIP
Apr 9, 2024 11:00am
